Preparation of pixantrone/poly(γ-glutamic acid) nanoparticles through complex self-assembly for oral chemotherapy

Macromol Biosci. 2012 Nov;12(11):1524-33. doi: 10.1002/mabi.201200137. Epub 2012 Sep 24.

Abstract

A facile and green approach is reported to construct pixantrone/poly(γ-glutamic acid) nanoparticles (PIX/γ-PGA NPs) as an oral drug delivery system through the complex self-assembly of polyelectrolyte γ-PGA and the anticancer drug pixantrone dimaleate (PDM). The complex self-assembly behavior is investigated in detail. The results demonstrate that PDM can interact with γ-PGA to conveniently form NPs and the size of NPs can be controlled by adjusting the solution volume ratio of PDM to γ-PGA. These NPs illustrate their pH-dependent release behavior, efficient cellular uptake and enhanced drug efficacy through an in vitro release study, flow cytometry, CLSM analysis and the MTT assay. In summary, PIX/γ-PGA NPs may serve as a promising oral drug delivery system for cancer therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Biological Transport
  • Cell Survival / drug effects
  • Drug Carriers / chemistry*
  • Drug Compounding
  • Flow Cytometry
  • Humans
  • Hydrogen-Ion Concentration
  • Isoquinolines / chemistry
  • Isoquinolines / pharmacology*
  • Kinetics
  • Mice
  • Microscopy, Electron, Scanning
  • NIH 3T3 Cells
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Neoplasms / drug therapy
  • Particle Size
  • Polyglutamic Acid / analogs & derivatives*
  • Polyglutamic Acid / chemistry
  • Spectroscopy, Fourier Transform Infrared

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Isoquinolines
  • poly(gamma-glutamic acid)
  • Polyglutamic Acid
  • pixantrone